A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
Active, not recruiting · NCT06733441 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Active, not recruiting | Phase 1 | 2026-08-18 | NCT06733441 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Treeline Biosciences, Inc. | 4 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| British Columbia Cancer Agency | Vancouver | Canada | 2 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Sarah Cannon Research Institute | Nashville | United States | 119 |
| Stanford Cancer Institute | Stanford | United States | 19 |
| Washington University School of Medicine | St Louis | United States | 895 |